Please login to the form below

pediatrics

This page shows the latest pediatrics news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Orchard gains rare disease status for ex-GSK therapy. Orchard Therapeutics has been granted an FDA Rare Pediatric Disease Designation for its rare disease gene therapy candidate OTL-200, which it

Latest news

Dr Reddy's brings its generics portfolio to France

Meanwhile, in its home country it is targeting a number of therapy areas, having agreed a 118m deal with UCB in 2015 to acquire a portfolio of dermatology, respiratory and pediatric
Lilly pilots enhanced online trial information

The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with
Biogen buys into Ionis' nusinersen after positive phase III trial

Potential blockbuster spinal muscular atrophy drug will be filed “in the coming months” 
Celebrating excellence

The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
PMEA 2015 win for Novo's Changing Diabetes in Children

The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolsecent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest Intelligence

The trials and tribulations of rare opportunities

Preclinical trials of rare disease drugs are challenging, said Jeffrey Keefer, MD VP, Medical Strategy Head of Pediatric and Rare Disease at IQVIA.
Implementing eHealth innovation

The first results from the global, five-year observational study in children with growth disorders was presented at the 10th International Meeting of Pediatric Endocrinology in September 2017.
Case study: The KiDS project in India and Brazil

Client:Sanofi, the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes. ... In response to this, the KiDS project was established by the International Diabetes Federation and the International Society for
Paging Dr Millennial

Almost 50% of the world's population today is under 25 years old, which means that family planning, women's health and pediatrics will be growing elements of the world's
Pharma deals in August 2015

In 2012 the PRV programme was extended to include rare pediatric diseases and the emergence of trading in PRVs was noted in our last annual Deal Watch report.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

BMS appoints oncology development head

As a trained pediatric oncologist, Fouad brings to this role exceptional clinical experience and an unwavering commitment to patients.
Dr Andrew Mulberg moves from FDA to Amicus Therapeutics

Dr Mulberg is a pediatric gastroenterologist, and was attending physician and fellowship director in gastroenterology and hepatology for The Children's Hospital of Philadelphia between 1993 and 2001. ... He is currently the board chairman and member of
Former PEPFAR head Mark Dybul to lead the Global Fund

In addition to his new post, Dr Dybul currently serves as a director on several executive and advisory boards of health organisations, including Malaria No More, the Elizabeth Glaser Pediatric AIDS

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Mastering the precision medicine opportunity

Last year the FDA made a pioneering move in this space and approved Keytruda for use in adult and pediatric patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.